• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恒定或周期性扰动下肿瘤-宿主系统竞争型Lotka-Volterra模型的动力学:对癌症治疗的启示

Dynamic of competitive Lotka-Volterra model for tumor-host systems under constant or periodic perturbation: Implications for the therapy of cancer.

作者信息

Jimenez Rolando Placeres, Bergues Cabrales Luis E, Montijano Juan I

机构信息

Grupo de Simulaç ao Computacional, Departamento de Física, Universidade Federal de S ao Carlos, S ao Carlos, S ao Paulo, Brazil.

Departamento de Investigación e Innovación, Centro Nacional de Electromagnetismo Aplicado, Universidad de Oriente, Santiago de Cuba, Cuba.

出版信息

PLoS One. 2025 Aug 25;20(8):e0329087. doi: 10.1371/journal.pone.0329087. eCollection 2025.

DOI:10.1371/journal.pone.0329087
PMID:40853989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12377631/
Abstract

In this paper, the tumor-host interaction is modeled using a Lotka-Volterra framework. The critical parameters that define the possible dynamical regimes are identified through linear stability analysis. The effects of both constant and periodic perturbations are examined, along with their clinical implications. The treatment dose required to drive the system to a desired state is determined. It is also shown that aggressive tumors evolve toward a limit cycle when the host is under the action of low-frequency periodic treatment. As the frequency increases, a transition to a non-chaotic attractor occurs. This transition narrows as the frequency of the external periodic perturbation increases. No chaotic behavior is observed, even at higher values of both perturbation strength and frequency, as the maximum Lyapunov exponent remains negative. These results suggest that although aggressive tumors may not be completely eradicated by conventional anticancer therapies, they could potentially be controlled through external low-frequency periodic treatments that target directly only the host, such as immunotherapy.

摘要

在本文中,肿瘤-宿主相互作用是使用洛特卡-沃尔泰拉框架进行建模的。通过线性稳定性分析确定了定义可能动态状态的关键参数。研究了恒定扰动和周期性扰动的影响及其临床意义。确定了将系统驱动到期望状态所需的治疗剂量。研究还表明,当宿主受到低频周期性治疗作用时,侵袭性肿瘤会朝着极限环演化。随着频率增加,会发生向非混沌吸引子的转变。随着外部周期性扰动频率的增加,这种转变会变窄。即使在扰动强度和频率较高时也未观察到混沌行为,因为最大李雅普诺夫指数仍为负。这些结果表明,尽管侵袭性肿瘤可能无法通过传统抗癌疗法完全根除,但通过直接仅针对宿主的外部低频周期性治疗(如免疫疗法),它们有可能得到控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/8a5bd5c3a460/pone.0329087.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/dd0ace3202d5/pone.0329087.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/897d6feb05a2/pone.0329087.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/f174d3bc6b04/pone.0329087.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/057a941f4931/pone.0329087.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/be1416af8491/pone.0329087.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/67077bbe436b/pone.0329087.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/2eba87ca2fe5/pone.0329087.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/8a5bd5c3a460/pone.0329087.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/dd0ace3202d5/pone.0329087.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/897d6feb05a2/pone.0329087.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/f174d3bc6b04/pone.0329087.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/057a941f4931/pone.0329087.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/be1416af8491/pone.0329087.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/67077bbe436b/pone.0329087.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/2eba87ca2fe5/pone.0329087.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c7/12377631/8a5bd5c3a460/pone.0329087.g008.jpg

相似文献

1
Dynamic of competitive Lotka-Volterra model for tumor-host systems under constant or periodic perturbation: Implications for the therapy of cancer.恒定或周期性扰动下肿瘤-宿主系统竞争型Lotka-Volterra模型的动力学:对癌症治疗的启示
PLoS One. 2025 Aug 25;20(8):e0329087. doi: 10.1371/journal.pone.0329087. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
4
Sexual Harassment and Prevention Training性骚扰与预防培训
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Electrophoresis电泳
7
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
8
Healthcare workers' informal uses of mobile phones and other mobile devices to support their work: a qualitative evidence synthesis.医护人员非正规使用手机和其他移动设备来支持工作:定性证据综合评价。
Cochrane Database Syst Rev. 2024 Aug 27;8(8):CD015705. doi: 10.1002/14651858.CD015705.pub2.
9
Systemic Inflammatory Response Syndrome全身炎症反应综合征
10
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.

本文引用的文献

1
Pulsed Electromagnetic Field Therapy Alters the Genomic Profile of Bladder Cancer Cell Line HT-1197.脉冲电磁场疗法改变膀胱癌细胞系HT-1197的基因组图谱。
J Pers Med. 2025 Apr 4;15(4):143. doi: 10.3390/jpm15040143.
2
Exploring the Immunoresponse in Bladder Cancer Immunotherapy.探索膀胱癌免疫治疗中的免疫反应。
Cells. 2024 Nov 22;13(23):1937. doi: 10.3390/cells13231937.
3
Optimized patient-specific immune checkpoint inhibitor therapies for cancer treatment based on tumor immune microenvironment modeling.基于肿瘤免疫微环境建模的癌症治疗优化的个体化免疫检查点抑制剂治疗。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae547.
4
Pulsed electromagnetic fields regulate metabolic reprogramming and mitochondrial fission in endothelial cells for angiogenesis.脉冲电磁场调节血管生成内皮细胞的代谢重编程和线粒体分裂。
Sci Rep. 2024 Aug 16;14(1):19027. doi: 10.1038/s41598-024-69862-x.
5
Tissue-resident memory T cells in immunotherapy and immune-related adverse events by immune checkpoint inhibitor.组织驻留记忆 T 细胞在免疫治疗和免疫检查点抑制剂相关不良事件中的作用。
Int J Cancer. 2024 Jul 15;155(2):193-202. doi: 10.1002/ijc.34940. Epub 2024 Mar 30.
6
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.抗 PD-1、HDAC 抑制剂和抗 VEGF 联合治疗 MSS/pMMR 结直肠癌:一项随机 2 期试验。
Nat Med. 2024 Apr;30(4):1035-1043. doi: 10.1038/s41591-024-02813-1. Epub 2024 Mar 4.
7
A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way.癌症免疫治疗新时代:单克隆抗体开辟道路。
Eur J Pharmacol. 2024 Apr 15;969:176451. doi: 10.1016/j.ejphar.2024.176451. Epub 2024 Feb 24.
8
Immune-Related Adverse Events of Immune Checkpoint Inhibitors.免疫检查点抑制剂的免疫相关不良反应。
Ann Intern Med. 2024 Feb;177(2):ITC17-ITC32. doi: 10.7326/AITC202402200. Epub 2024 Feb 13.
9
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.在抗检查点单克隆抗体疗法时代,揭示B细胞和自身抗体介导的抗肿瘤免疫反应与自身免疫之间的复杂相互作用。
Front Immunol. 2024 Jan 22;15:1343020. doi: 10.3389/fimmu.2024.1343020. eCollection 2024.
10
Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy.接受免疫检查点抑制剂(ICPi)联合抗血管内皮生长因子(anti-VEGF)治疗患者的肾损伤的临床病理特征。
J Clin Pathol. 2024 Jun 19;77(7):471-477. doi: 10.1136/jcp-2023-209173.